SafeBeat logo

SafeBeatGuiding cardiac therapeutics - all from your phone

38 million people suffer from heart rhythm disorders and are recommended to start medications that can save their lives, but require rigorous ECG monitoring to start and remain on these pills. SafeBeat Rx moves beyond diagnostics to guide these therapeutics, powered by our ML ECG software that integrates with existing FDA-cleared wearables to allow seamless physician approval of drug dosing, all from a mobile phone. We are a team of physicians, engineers, data scientists, and machine learning experts dedicated to using engineering to improve heart health.

2021-07-27
Active
Early
S21
9
Healthcare
United States of AmericaAmerica / CanadaRemotePartly Remote
SafeBeat screenshot
More About SafeBeat

SafeBeat Rx - Powering Cardiac Therapeutics from Your Phone

Introduction

SafeBeat Rx goes beyond diagnostics to guide cardiac care. Our artificial intelligence technology powers the SafeBeat platform to expand access to remote patient monitoring (RPM) using third-party FDA-cleared cardiac monitoring devices and software-enabled therapeutic monitoring, all from your phone.

Key Features

  • Remote Patient Monitoring (RPM): Utilize mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors.
  • Software-Enabled Therapeutic Monitoring: Streamlined for mobile use with explainable AI and custom tools.
  • Advanced AI Algorithms: Proprietary machine learning algorithms for ECG interpretation and treatment management.
  • Clinician-Centric Design: Designed by clinicians to minimize alerts and notifications, focusing on actionable insights.
  • Patient and Clinician Experience: Prioritizes user experience to unlock the full capabilities of digital health and remote care.

Use Cases

  • Cardiac Monitoring: Continuous monitoring for patients with heart rhythm disorders.
  • Remote Therapeutic Management: Manage treatments remotely, reducing the need for in-patient visits.
  • Clinical Decision Support: Provides clinicians with treatment recommendations based on real-time data.
  • Healthcare Accessibility: Expands access to cardiac care for underserved populations.
  • Cost Efficiency: Reduces healthcare costs by minimizing the need for in-patient monitoring.

Pricing

SafeBeat Rx is currently under development and not available for sale. It is limited by Federal (or United States) Law to Investigational Use Only.

Teams

Founders

  • Rachita Navara, MD, FACC, FHRSEP: Cardiologist and Bioengineer, Co-founder and CEO. Internationally recognized for atrial fibrillation research.
  • Kunj G. Patel, MD, MSc: Pain Physician and Mathematician, Co-founder, President, CTO. Expert in applied mathematics and translational research.

Leadership Team

  • John Higgins, BSc: Director of Engineering with 13 years of experience in software engineering and AI platforms.
  • Alejandro Alvarez, MSc: Founding and Lead Engineer with a background in signal processing and telecommunication.
  • Ben Sackett, MSc: Head of Operations & Technical Lead, former senior engineer at Genentech.
  • Rania deLeon, BSc: Regulatory Affairs Manager with seven years of experience in the medical device industry.

Our integrated technology expands access to remote patient monitoring (RPM), event monitoring, software-enabled remote therapeutic monitoring (RTM), and cardiac implantable electronic device monitoring – all powered by our streamlined artificial intelligence-based software.